Search Filters
Advanced Search
SMC ID Date Medicine Submission Type Indication
1135/16 09/05/2016 bevacizumab (Avastin) Full In combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix.
1063/15 07/09/2015 bevacizumab (Avastin) Full In combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vascular endothelial growth factor (VEGF) inhibitors or VEGF receptor-targeted agents
545/09 14/04/2009 topotecan hydrochloride (Hycamtin) Full Monotherapy for the treatment of adult patients with relapsed small cell lung cancer (SCLC)
421/07 10/12/2007 topotecan (Hycamtin) Full Carcinoma of the cervix
366/07 07/05/2007 topotecan 1mg, 4mg powder for concentrate for solution for infusion hydrochloride (Hycamtin) Full Relapsed small cell lung cancer

No medicines have been found.